Navigation Links
Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging
Date:7/22/2014

MOUNTAIN VIEW, Calif., July 22, 2014 /PRNewswire/ -- Based on its recent analysis of the magnetic resonance imaging (MRI) market, Frost & Sullivan recognizes Siemens Healthcare with the 2014 North American Award for Product Leadership. Siemens Healthcare's FREEZEit solution, which employs Siemens' MAGNETOM Aera and Skyra scanners, addresses the need for robust and motion-insensitive imaging. The solution's sophistication and utility in patient care has boosted the evolution of body MRI imaging in the U.S. market.

"Currently, body MR imaging, which is the imaging of the chest, abdomen and pelvis, represents about 10 percent of the MR imaging procedure volume; yet some institutions have experienced a tripling of body referrals within a few years," said Frost & Sullivan Principal Analyst Nadim Daher. "One of the reasons for their growth was the delivery of rapid, consistent exams that patients could complete even with limited breath-holding capabilities."

Conventional MR imaging is sensitive to motion, whether voluntary (respiratory motion or physical movement by the patient) or involuntary (cardiac motion, bowel motion). Body MR imaging also requires the patient to hold their breath in order to achieve diagnostic image quality; however, children, the elderly or very sick patients find it difficult to comply with the breath-hold commands. Traditional systems also need robust fat suppression to amplify the conspicuity of the vessels and lesions. Furthermore, contrast timing is vital for the characterization of lesions by these systems.

StarVIBE and TWIST-VIBE, the two components of FREEZEit, enable providers to overcome these challenges and expand their body MR referrals beyond computed tomography, the preferred modality up to this point. Referring physicians now have the opportunity to choose imaging modalities without radiation doses, especially in cases such as hemangiomas, focal nodular hyperplasia (FNH) and benign adenomas, which need repeat exams throughout the lifetime of the patient.

StarVIBE intelligently resists motion artifacts and, therefore, facilitates free-breathing 3D T1 exams. This will allow for much faster exams and fewer repeat scans, which, in turn, will enable providers to schedule patients for shorter slots, enhance the utilization rate of their equipment and, ultimately, increase their revenue.

Meanwhile, TWIST-VIBE provides dynamic liver imaging with high temporal and spatial resolution and full 4D coverage. It catches the precise point of the arterial phase when using contrast so that even almost invisible liver lesions can be detected. This technology has an immediate impact on treatment decisions, saving time and costs for caregivers and patients.

"Siemens realized MRI's untapped potential in body applications and is truly acting as a driver of progress in the MRI market," noted Daher. "Its innovations have had a significant impact on patient care and can potentially help healthcare providers improve their efficiency and lower their costs."

The company has leveraged technology innovation, product excellence and quality of service to advance clinical and patient outcomes, while enhancing the overall value and cost-efficiency of care. In recognition, Frost & Sullivan is pleased to present the 2014 Product Leadership Award to Siemens Healthcare.

Each year, Frost & Sullivan presents this award to the company that has demonstrated innovation in product features and functionality that provides enhanced quality and higher value to customers. The award recognizes the rapid acceptance such innovation finds in the marketplace.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About Siemens Healthcare

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 52,000 employees worldwide and operates around the world. In fiscal year 2013 (to September 30), the Sector posted revenue of 13.6 billion euros and profit of 2.0 billion euros. For further information please visit: www.siemens.com/healthcare.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Contact:

Mireya Espinoza
P: 210. 247.3870
F: 210.348.1003
E: mireya.espinoza@frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan Finds Wellness and Early Intervention Technologies Core Components in Healthcare Delivery Transformation
2. Frost & Sullivan Acknowledges Nanomades Unique Technology that Combines Multipoint Touch and Force Sensing on a Fully Flexible Substrate
3. Microlife Wins Accolades from Frost & Sullivan for its Unique Automated Oscillometric Blood Pressure Monitor
4. Frost & Sullivan Applauds Definiens Strong Technology Portfolio for the Effective Data Analysis of Histology Images
5. Frost & Sullivan Applauds EOS Imaging for its Highly Innovative, X-ray-Based Imaging Modality for Orthopedics
6. Frost & Sullivan Honours CompAir for its Advanced D-Series 2-Stage Oil-Free Screw Compressor
7. Frost & Sullivan Applauds Check-Cap for Pioneering a Non-invasive, Prep-Free Wireless Capsule Endoscope
8. Frost & Sullivan: Rising Disease Incidence Boosts Future Uptake of Multiparameter Patient Monitoring in Europe
9. Frost & Sullivan Recognizes the Strong Adaptability of ActiveHealths CareEngine Solution
10. Frost & Sullivan Examines the Future of On-Demand Mobile Personal Health Records
11. Frost & Sullivan Unveils Future Opportunities for the Tissue Diagnostics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... LONDON , April 19, 2017 ... to stimulate an immune response in pets such ... vaccine products are of various types such as ... Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. ... such as virus or bacteria, which have been ...
Breaking Medicine Technology:
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders in safe, ... award-winning sunscreen they’ve used the same scientific approach to solving smelly, sweaty athletes, ... the aisles that contain harmful chemicals that should be put nowhere near your ...
(Date:4/27/2017)... , ... April 27, 2017 , ... ... today announced an exhibitor sponsorship at MobileIron Live! 2017 in Santa ... technologies for an immersive, educational approach to helping organizations maximize the benefits of ...
(Date:4/27/2017)... ... ... Are you investing in the safety of your friends and family? Each year, ... most of us assume this type of accident will never happen to us, the ... the time to learn how to respond effectively or prevent these accidents from occurring ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... outcomes, today released the podcast, “Make Plans for MACRA,” highlighting the ... into the physician's office and how physicians and other clinicians are reimbursed for ...
(Date:4/26/2017)... ... 2017 , ... CareSet Labs today is releasing an important ... Part D Medicare data. The dataset, called PaPR (Providers and Prescribing Records) details ... paper. The PaPR (pronounced "paper") data set aggregates this information on a ...
Breaking Medicine News(10 mins):